7:07 am Synageva Biopharma issued U.S. patent for treatment of LAL deficiency – HedgeChatter

7:07 am Synageva Biopharma issued U.S. patent for treatment of LAL deficiency

05 Mar

7:07 am Synageva Biopharma issued U.S. patent for treatment of LAL deficiency

Bystocknews GEVA, stock Comments Off

View todays social media effects on GEVA

View the latest stocks trending across Twitter. Click to view dashboard

See who Synageva is hiring next, click here to view

Author